Related Experiment Video
Updated: Aug 7, 2025
15:04
Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils
Published on: September 28, 2019
6.0K
Probing the interactions between amyloidogenic proteins and bio-membranes
Liang Ma1, Xi Li2, Robert B Petersen3
1Department of Pharmacy, Wuhan Mental Health Center, Wuhan, China; Department of Pharmacy, Wuhan Hospital for Psychotherapy, Wuhan, China.
Biophysical Chemistry
|March 8, 2023
Summary
Protein misfolding diseases involve protein aggregates and their interaction with bio-membranes. This review explores how bio-membranes influence protein aggregation and cause cell damage, alongside therapeutic strategies.
Area of Science:
- Biochemistry
- Cell Biology
- Neuroscience
Background:
- Protein misfolding diseases (PMDs) are linked to protein aggregate deposition in tissues, affecting conditions like Alzheimer's and Parkinson's.
- Amyloidogenic protein misfolding and aggregation are central to PMD pathogenesis.
- The interaction between proteins and biological membranes significantly influences these aggregation processes.
Purpose of the Study:
- To review factors governing amyloidogenic protein-membrane interactions.
- To elucidate the impact of bio-membranes on protein aggregation.
- To explore mechanisms of membrane disruption by protein aggregates and discuss therapeutic interventions.
Main Methods:
- Literature review focusing on protein-misfolding diseases and membrane interactions.
- Analysis of studies investigating bio-membrane effects on protein aggregation.
- Examination of research on membrane disruption mechanisms and detection techniques.
Main Results:
- Bio-membranes induce conformational changes in proteins, modulating aggregation.
- Protein aggregates can damage membranes, leading to cytotoxicity.
- Various technical approaches exist for studying these protein-membrane interactions.
Conclusions:
- Understanding protein-membrane interactions is crucial for PMD pathogenesis.
- Targeting membrane damage offers a potential therapeutic avenue for PMDs.
- Further research into these interactions can guide novel treatment strategies.
Related Concept Videos
03:03Amyloid Fibrils
9.7K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.7K
00:59Mechanisms of Membrane Domain Formation
3.1K
Different physical properties of lipids and proteins allow them to localize and form distinct islands or domains in the membrane. Some membrane domains are formed due to protein-protein interactions, whereas others are formed due to the presence of specific lipids such as sphingolipids and sterols—for example, large proteins, such as bacteriorhodopsin, aggregate and create distinct domains.
Another mechanism for membrane domain formation involves membrane proteins interacting with...
Another mechanism for membrane domain formation involves membrane proteins interacting with...
3.1K
01:09Multi-pass Transmembrane Proteins and β-barrels
5.4K
In multi-pass transmembrane proteins, the polypeptide chain crosses the membrane more than once. The transmembrane polypeptide chain either forms an α-helix or β-strand structure. α-Helix containing multi-pass transmembrane proteins are ubiquitous, whereas β-strand containing ones are mainly found in gram-negative bacteria, mitochondria, and chloroplasts.
α-Helix containing multi-pass transmembrane proteins
Multi-pass transmembrane proteins such as...
α-Helix containing multi-pass transmembrane proteins
Multi-pass transmembrane proteins such as...
5.4K
01:35Asymmetric Lipid Bilayer
7.3K
Biological membranes show uneven distribution of different types of lipids in the inner and outer layers, resulting in transverse asymmetric membranes. The treatment of the erythrocyte membrane with the enzyme phospholipase confirmed the asymmetric nature of the lipid bilayer. The enzyme hydrolyzes lipids into fatty acids and hydrophilic groups. The phospholipase acts only on the outer layer of the membrane, while the inner layer remains intact. The phospholipase treatment resulted in 80%...
7.3K
01:15Mechanisms of Membrane-bending
2.7K
The living membranes are flexible due to their fluid mosaic nature; however, their bending into different shapes is an active process regulated by specific lipids and proteins. The membrane bending can be transient as seen in vesicles or stable for a long time as in microvilli. Cells regulate the size, location, and duration of the membrane curvature.
Membrane bending can happen due to intrinsic changes in lipid composition or extrinsic association with different proteins. The proteins involved...
Membrane bending can happen due to intrinsic changes in lipid composition or extrinsic association with different proteins. The proteins involved...
2.7K
01:18Membrane Domains
5.5K
The membrane domains concentrate specific lipids and proteins at one place within the membrane, which helps in cell signaling, adhesion, and other critical cellular processes. These domains can differ in size, composition, function, and lifespan.
Protein Domains
The membrane comprises a group of distinct proteins responsible for carrying out a cell's specific function. For example, the plasma membrane of the human sperm, or a single germ cell, contains a unique set of proteins in the...
Protein Domains
The membrane comprises a group of distinct proteins responsible for carrying out a cell's specific function. For example, the plasma membrane of the human sperm, or a single germ cell, contains a unique set of proteins in the...
5.5K